1. Market Research
  2. > Healthcare Market Trends
  3. > Healthcare Analysis & Statistics, September 2019 (p2)

Healthcare Analysis & Statistics, September 2019 (p2)

Customer Support

Talk to Ahmad

+1 718 618 4302

Publication dates

Publishers

All regions

31-60 of about 41000 reports

Global Automated Microbiology Market for over 100 Tests

Global Automated Microbiology Market for over 100 Tests

  • $ 18500
  • Industry report
  • September 2019

Global Automated Microbiology Market for over 100 Tests: US, Europe, JapanLeadingMarketResearch.com's new report is a seven-country strategic analysis of the major business opportunities emerging ...

  • Industries : Pathology
  • Countries : World, United States, Japan
Global Virology and Bacteriology Market for over 100 Tests: US, Europe, Japan--Supplier Shares and Strategies, Test Volume and Sales Segment Forecasts, Technology and Instrumentation Review

Global Virology and Bacteriology Market for over 100 Tests: US, Europe, Japan--Supplier Shares and Strategies, Test Volume and Sales Segment Forecasts, Technology and Instrumentation Review

  • $ 18500
  • Industry report
  • September 2019

Global Virology and Bacteriology Market for over 100 Tests: US, Europe, Japan--Supplier Shares and Strategies, Test Volume and Sales Segment Forecasts, Technology and Instrumentation ReviewThis new report ...

  • Industries : Pathology
  • Countries : Japan, World, United States, Europe
Europe Hemostasis Diagnostic Analyzers and Reagent Market for over 40 Tests: A 31-Country Analysis--Supplier Shares and Strategies, Volume and Sales Segment Forecasts, Technology and Instrumentation Review

Europe Hemostasis Diagnostic Analyzers and Reagent Market for over 40 Tests: A 31-Country Analysis--Supplier Shares and Strategies, Volume and Sales Segment Forecasts, Technology and Instrumentation Review

  • $ 18500
  • Industry report
  • September 2019

Europe Hemostasis Diagnostic Analyzers and Reagent Market for over 40 Tests: A 31-Country Analysis--Supplier Shares and Strategies, Volume and Sales Segment Forecasts, Technology and Instrumentation ReviewThis ...

  • Industries : Diagnostics, In Vitro Diagnostics, In Vitro Diagnostics
  • Countries : Northern Europe, Scandinavia, Baltics, Europe, Netherlands, Western Europe
Europe Transfusion Diagnostics Market for 40 Immunohematology and NAT Assays: A 31-Country Analysis--Supplier Shares and Strategies, Volume and Sales Segment Forecasts, Emerging Technologies,     Instrumentation and Opportunities

Europe Transfusion Diagnostics Market for 40 Immunohematology and NAT Assays: A 31-Country Analysis--Supplier Shares and Strategies, Volume and Sales Segment Forecasts, Emerging Technologies, Instrumentation and Opportunities

  • $ 18500
  • Industry report
  • September 2019

Europe Transfusion Diagnostics Market for 40 Immunohematology and NAT Assays: A 31-Country Analysis--Supplier Shares and Strategies, Volume and Sales Segment Forecasts, Emerging Technologies, Instrumentation ...

  • Industries : Pathology
  • Countries : Northern Europe, Scandinavia, Baltics, Europe
Europe Infectious Disease Testing Market for Over 100 Tests: A 31-Country Analysis--Supplier Shares and Strategies, Test Volume and Sales Segment Forecasts, Technology and Instrumentation Review

Europe Infectious Disease Testing Market for Over 100 Tests: A 31-Country Analysis--Supplier Shares and Strategies, Test Volume and Sales Segment Forecasts, Technology and Instrumentation Review

  • $ 18500
  • Industry report
  • August 2019

Europe Infectious Disease Testing Market for Over 100 Tests: A 31-Country Analysis--Supplier Shares and Strategies, Test Volume and Sales Segment Forecasts, Technology and Instrumentation ReviewThis new ...

  • Industries : Pathology
  • Countries : Northern Europe, Scandinavia, Baltics
Global Hematology and Flow Cytometry Market, 2019-2023: Analyzers and Reagents--Supplier Shares and Strategies, Country Segment Forecasts, Innovative Technologies, Instrumentation Review

Global Hematology and Flow Cytometry Market, 2019-2023: Analyzers and Reagents--Supplier Shares and Strategies, Country Segment Forecasts, Innovative Technologies, Instrumentation Review

  • $ 14500
  • Industry report
  • November 2019

Global Hematology and Flow Cytometry Market, 2019-2023: Analyzers and Reagents--Supplier Shares and Strategies, Country Segment Forecasts, Innovative Technologies, Instrumentation ReviewLeadingMarketResearch.com ...

  • Industries : Diagnostics
  • Countries : World
Competing in the POC Diagnostic Testing Market: Supplier Shares, Segment Forecasts for 300 Tests, Growth Opportunities

Competing in the POC Diagnostic Testing Market: Supplier Shares, Segment Forecasts for 300 Tests, Growth Opportunities

  • $ 14500
  • Industry report
  • November 2019

Competing in the POC Diagnostic Testing Market: Supplier Shares, Segment Forecasts for 300 Tests, Growth OpportunitiesThis new 1,230-page report contains 343 tables, and provides a comprehensive analysis ...

  • Industries : Diagnostics
Global Nucleic Acid Testing/NAT Market, 2019-2023: Emerging Opportunities in US, Europe, Japan--Supplier Shares and Strategies, Country Volume and Sales Segment Forecasts--Infectious and Genetic Diseases, Cancer, Forensic and Paternity Testing

Global Nucleic Acid Testing/NAT Market, 2019-2023: Emerging Opportunities in US, Europe, Japan--Supplier Shares and Strategies, Country Volume and Sales Segment Forecasts--Infectious and Genetic Diseases, Cancer, Forensic and Paternity Testing

  • $ 14500
  • Industry report
  • October 2019

Global Nucleic Acid Testing/NAT Market, 2019-2023: Emerging Opportunities in US, Europe, Japan--Supplier Shares and Strategies, Country Volume and Sales Segment Forecasts--Infectious and Genetic Diseases, ...

  • Industries : Diagnostics
  • Countries : Japan, United States, World, Europe
Global Molecular Diagnostic Analyzers and Reagent Forecasts for 100 Tests: USA, Europe, Japan--Infectious and Genetic Diseases, Cancer, Forensic and Paternity Testing--Supplier Shares, Emerging Technologies, Instrumentation Review, Opportunities

Global Molecular Diagnostic Analyzers and Reagent Forecasts for 100 Tests: USA, Europe, Japan--Infectious and Genetic Diseases, Cancer, Forensic and Paternity Testing--Supplier Shares, Emerging Technologies, Instrumentation Review, Opportunities

  • $ 14500
  • Industry report
  • October 2019

Global Molecular Diagnostic Analyzers and Reagent Forecasts for 100 Tests: USA, Europe, Japan--Infectious and Genetic Diseases, Cancer, Forensic and Paternity Testing--Supplier Shares, Emerging Technologies, ...

  • Industries : Diagnostics
  • Countries : Japan, United States, World, Europe
Coagulation Testing Analyzers and Reagents Market for Over 40 Tests: US, Europe, Japan--Supplier Shares and Strategies, Volume and Sales Segment Forecasts, Technology and Instrumentation Review

Coagulation Testing Analyzers and Reagents Market for Over 40 Tests: US, Europe, Japan--Supplier Shares and Strategies, Volume and Sales Segment Forecasts, Technology and Instrumentation Review

  • $ 14500
  • Industry report
  • August 2019

Coagulation Testing Analyzers and Reagents Market for Over 40 Tests: US, Europe, Japan--Supplier Shares and Strategies, Volume and Sales Segment Forecasts, Technology and Instrumentation ReviewSummaryThis ...

  • Industries : Diagnostics, In Vitro Diagnostics, In Vitro Diagnostics
  • Countries : United States, Japan, Europe, World
Europe Coagulation Testing Analyzers and Reagents Market for Over 40 Tests: A 31-Country Analysis--Supplier Shares and Strategies, Volume and Sales Segment Forecasts, Technology and Instrumentation Review, Emerging Opportunities

Europe Coagulation Testing Analyzers and Reagents Market for Over 40 Tests: A 31-Country Analysis--Supplier Shares and Strategies, Volume and Sales Segment Forecasts, Technology and Instrumentation Review, Emerging Opportunities

  • $ 14500
  • Industry report
  • August 2019

Europe Coagulation Testing Analyzers and Reagents Market for Over 40 Tests: A 31-Country Analysis--Supplier Shares and Strategies, Volume and Sales Segment Forecasts, Technology and Instrumentation Review, ...

  • Industries : Diagnostics, In Vitro Diagnostics, In Vitro Diagnostics
  • Countries : Northern Europe, Scandinavia, Baltics, Europe, Netherlands, Western Europe
Europe Automated Microbiology Market for over 100 Tests

Europe Automated Microbiology Market for over 100 Tests

  • $ 12900
  • Industry report
  • September 2019

Europe Automated Microbiology Market for over 100 Tests: France, Germany, Italy, Spain, UKThis new report is a five-country strategic analysis of the major business opportunities emerging in the automated ...

  • Industries : Pathology
  • Countries : Europe, France, Germany, Italy, Spain, United Kingdom
Europe Virology and Bacteriology Market for over 100 Tests: France, Germany, Italy, Spain, UK--Supplier Shares and Strategies, Test Volume and Sales Segment Forecasts, Technology and Instrumentation Review

Europe Virology and Bacteriology Market for over 100 Tests: France, Germany, Italy, Spain, UK--Supplier Shares and Strategies, Test Volume and Sales Segment Forecasts, Technology and Instrumentation Review

  • $ 12800
  • Industry report
  • September 2019

Europe Virology and Bacteriology Market for over 100 Tests: France, Germany, Italy, Spain, UK--Supplier Shares and Strategies, Test Volume and Sales Segment Forecasts, Technology and Instrumentation ReviewThis ...

  • Industries : Pathology
  • Countries : Germany, Italy, Spain, Europe, France, United Kingdom
Europe Hemostasis Diagnostic Analyzers and Reagent Market for over 40 Tests: France, Germany, Italy, Spain, UK--Supplier Shares and Strategies, Volume and Sales Segment Forecasts, Technology and Instrumentation Review

Europe Hemostasis Diagnostic Analyzers and Reagent Market for over 40 Tests: France, Germany, Italy, Spain, UK--Supplier Shares and Strategies, Volume and Sales Segment Forecasts, Technology and Instrumentation Review

  • $ 12800
  • Industry report
  • September 2019

Europe Hemostasis Diagnostic Analyzers and Reagent Market for over 40 Tests: France, Germany, Italy, Spain, UK--Supplier Shares and Strategies, Volume and Sales Segment Forecasts, Technology and Instrumentation ...

  • Industries : Diagnostics
  • Countries : France, Germany, Italy, Spain, United Kingdom, Europe
Europe Transfusion Diagnostics Market for 40 Immunohematology and NAT Assays: France, Germany, Italy, Spain, UK--Supplier Shares and Strategies, Volume and Sales Segment Forecasts, Latest Technologies and Instrumentation

Europe Transfusion Diagnostics Market for 40 Immunohematology and NAT Assays: France, Germany, Italy, Spain, UK--Supplier Shares and Strategies, Volume and Sales Segment Forecasts, Latest Technologies and Instrumentation

  • $ 12800
  • Industry report
  • September 2019

Europe Transfusion Diagnostics Market for 40 Immunohematology and NAT Assays: France, Germany, Italy, Spain, UK--Supplier Shares and Strategies, Volume and Sales Segment Forecasts, Latest Technologies ...

  • Industries : Pathology
  • Countries : Europe, France, Germany, Italy, Spain, United Kingdom
Europe Infectious Disease Testing Market for Over 100 Tests: Emerging Opportunities in France, Germany, Italy, Spain, UK--Supplier Shares and Strategies, Test Volume and Sales Segment Forecasts, Technology and Instrumentation Review

Europe Infectious Disease Testing Market for Over 100 Tests: Emerging Opportunities in France, Germany, Italy, Spain, UK--Supplier Shares and Strategies, Test Volume and Sales Segment Forecasts, Technology and Instrumentation Review

  • $ 12800
  • Industry report
  • August 2019

Europe Infectious Disease Testing Market for Over 100 Tests: Emerging Opportunities in France, Germany, Italy, Spain, UK--Supplier Shares and Strategies, Test Volume and Sales Segment Forecasts, Technology ...

  • Industries : Pathology
  • Countries : Germany, Italy, Spain, Europe, France, United Kingdom
POCT Forecasts for 300 Assays, Supplier Shares and Strategies, Instrumentation Review, Emerging Technologies

POCT Forecasts for 300 Assays, Supplier Shares and Strategies, Instrumentation Review, Emerging Technologies

  • $ 12500
  • Industry report
  • November 2019

POCT Forecasts for 300 Assays, Supplier Shares and Strategies, Instrumentation Review, Emerging TechnologiesVPGMarketResearch’s new report provides comprehensive analysis of the ten POC market segments, ...

  • Industries : Diagnostics
Global Infectious Disease Molecular Diagnostics Forecasts for 100 Tests: US, Europe, Japan--Supplier Shares, Competitive Strategies, Volume and Sales Segment Forecasts, Innovative Technologies, Instrumentation Review

Global Infectious Disease Molecular Diagnostics Forecasts for 100 Tests: US, Europe, Japan--Supplier Shares, Competitive Strategies, Volume and Sales Segment Forecasts, Innovative Technologies, Instrumentation Review

  • $ 12500
  • Industry report
  • November 2019

Global Infectious Disease Molecular Diagnostics Forecasts for 100 Tests: US, Europe, Japan--Supplier Shares, Competitive Strategies, Volume and Sales Segment Forecasts, Innovative Technologies, Instrumentation ...

  • Industries : Diagnostics
  • Countries : World, United States, Europe, Japan
Axial Spondyloarthritis: Global Drug Forecast and Market Analysis to 2028

Axial Spondyloarthritis: Global Drug Forecast and Market Analysis to 2028

  • $ 10995
  • Industry report
  • October 2019

Axial Spondyloarthritis: Global Drug Forecast and Market Analysis to 2028SummaryAxial spondyloarthritis (axSpA) is a disease group encompassing both ankylosing spondylitis (AS) and non-radiographic axial ...

  • Industries : Medical Biotechnology, Pharmaceutical, Therapy, Biopharmaceutical, Biopharmaceutical
  • Countries : United States, Japan, World
Female Infertility: Opportunity Analysis and Forecasts to 2028

Female Infertility: Opportunity Analysis and Forecasts to 2028

  • $ 10995
  • Industry report
  • September 2019

Female Infertility: Opportunity Analysis and Forecasts to 2028SummaryThe report “Female Infertility: Opportunity Analysis and Forecasts to 2028” expects the Female Infertility (FI) drug market to grow ...

  • Industries : Therapy, Pathology, Healthcare, Pharmaceutical
  • Countries : United States
Ovarian Cancer: Opportunity Analysis and Forecasts to 2028

Ovarian Cancer: Opportunity Analysis and Forecasts to 2028

  • $ 10995
  • Industry report
  • September 2019

Ovarian Cancer: Opportunity Analysis and Forecasts to 2028SummaryThe latest report “Ovarian Cancer: Opportunity Analysis and Forecasts to 2028” values the Ovarian Cancer market at $1.8bn in 2018 across ...

  • Industries : Cancer, Pathology, Therapy
  • Countries : United States, World, Japan
Hemophilia A and B - Global Drug Forecast and Market Analysis to 2028

Hemophilia A and B - Global Drug Forecast and Market Analysis to 2028

  • $ 10995
  • Industry report
  • August 2019

Hemophilia A and B - Global Drug Forecast and Market Analysis to 2028SummaryHemophilia A and B are rare, genetic, X-linked deficiencies in the blood clotting factors VIII (FVIII) and IX (FIX), respectively.Patients ...

  • Industries : Pathology, Healthcare
  • Countries : United States, World, China, East Asia, North America, Japan
Prostate Cancer: Global Drug Forecast and Market Analysis to 2028

Prostate Cancer: Global Drug Forecast and Market Analysis to 2028

  • $ 10995
  • Industry report
  • August 2019

Prostate Cancer: Global Drug Forecast and Market Analysis to 2028SummaryThe prostate cancer market will undergo a moderate increase at a compound annual growth rate (CAGR) of 3.3% from an estimated $9.3bn ...

  • Industries : Cancer, Therapy, Pathology
  • Countries : United States, East Asia, Japan, China, World, North America
Alopecia Areata: Opportunity Analysis and Forecasts to 2028

Alopecia Areata: Opportunity Analysis and Forecasts to 2028

  • $ 10995
  • Industry report
  • August 2019

Alopecia Areata: Opportunity Analysis and Forecasts to 2028SummaryAlopecia areata (AA) is the second most common non-scarring alopecia and there are no clear reasons for the onset of the condition; however, ...

  • Industries : Pathology, Therapy
  • Countries : United States
Allergic Rhinitis Immunotherapy: Opportunity Analysis and Forecasts to 2028

Allergic Rhinitis Immunotherapy: Opportunity Analysis and Forecasts to 2028

  • $ 10995
  • Industry report
  • August 2019

Allergic Rhinitis Immunotherapy: Opportunity Analysis and Forecasts to 2028SummaryAllergic rhinitis (AR) is a common, IgE-mediated inflammatory disease in which an individual reacts to an otherwise innocuous ...

  • Industries : Medical Biotechnology, Biopharmaceutical, Biopharmaceutical, Pharmaceutical, Chronic Disease, Pathology
  • Countries : United States, Japan, World, East Asia, North America
Cyramza

Cyramza

  • $ 10000
  • Industry report
  • September 2019

Drug OverviewCyramza (ramucirumab; Eli Lilly) is a fully human vascular endothelial growth factor receptor (VEGFR)-2-directed immunoglobulin G1 monoclonal antibody that binds to the extracellular domain ...

  • Industries : Cancer, Pathology
  • Countries : United States, Japan, European Union
Nexavar

Nexavar

  • $ 10000
  • Industry report
  • September 2019

Drug OverviewNexavar (sorafenib; Bayer/Amgen) is an orally available, multi-targeted tyrosine kinase inhibitor that is directed against several targets, including CRAF, BRAF, RET, KIT, FMS-like tyrosine ...

  • Industries : Pathology, Cancer, Therapy
  • Countries : United States, Japan, European Union
Tecentriq

Tecentriq

  • $ 10000
  • Industry report
  • September 2019

Drug OverviewTecentriq (atezolizumab; Roche/Chugai) is a fully humanized monoclonal antibody that targets programmed death-ligand 1 (PD-L1). PD-L1 is expressed on the surface of antigen-presenting cells ...

  • Industries : Cancer, Pathology
  • Countries : United States, European Union
Opdivo

Opdivo

  • $ 10000
  • Industry report
  • September 2019

Drug OverviewOpdivo (nivolumab; Bristol-Myers Squibb/Ono Pharmaceutical) is a fully human immunoglobulin G4 PD-1 immune checkpoint inhibitor that binds to the checkpoint receptor PD-1 expressed on activated ...

  • Industries : Cancer, Pathology
  • Countries : United States, European Union, Japan
tislelizumab

tislelizumab

  • $ 10000
  • Industry report
  • September 2019

Drug OverviewTislelizumab (BeiGene) is a humanized monoclonal antibody that was designed to bind to the PD-1 receptor and prevent binding of PD-L1. In addition, tislelizumab was designed to minimize binding ...

  • Industries : Pathology, Medical Biotechnology
  • Countries : United States

Reportlinker.com © Copyright 2019. All rights reserved.

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.

Make sure you don’t miss any news and follow us on